**Industry Distribution:**
1. **Pharmaceuticals:** approx. 45%
2. **Biotechnology:** approx. 25%
3. **Medical Devices:** approx. 20%
4. **Health Services:** approx. 10%

**TOP 3 Markets:**
1. **USA:** approx. 60%
2. **Europe:** approx. 25%
3. **Asia-Pacific:** approx. 10%

The iShares S&P 500 Health Care Sector UCITS ETF invests in companies operating in the healthcare sector, with a focus on pharmaceuticals, biotechnology, and medical devices. The USA is the dominant market, attributed to the strong presence and innovation of US healthcare companies. Europe and the Asia-Pacific region follow, with these markets also being significant due to growing populations and increasing healthcare expenditures.

**iShares V Public Limited Company** is a provider of Exchange Traded Funds (ETFs) and does not produce physical products.

iShares, a brand of BlackRock, offers a variety of ETFs that invest in different sectors and markets. The **iShares S&P 500 Health Care Sector UCITS ETF** invests in stocks of companies operating in the healthcare sector, based on the S&P 500 Health Care Index.

Being a financial service provider, there are no physical production facilities. The management and structuring of the ETFs are carried out by BlackRock's financial and investment teams.

**Strategy for Future Growth:**

The iShares S&P 500 Health Care Sector UCITS ETF (LSE:IUHC) follows a passive investment strategy.

The ETF aims to replicate the performance of the S&P 500 Health Care Sector Index. This strategy involves investing in a diversified selection of companies within the healthcare sector listed in the S&P 500 Index.

For future growth, the ETF relies on the continuous development and innovation in the healthcare sector, including biotechnology, pharmaceuticals, and medical technology. Demographic trends such as an aging population and increasing demand for healthcare services also support the growth potential of the ETF.

As the ETF is passively managed, the focus is on minimizing costs and maximizing the tracking accuracy of the underlying index.

**Commodities/Materials:** Not applicable

The iShares S&P 500 Health Care Sector UCITS ETF (LSE:IUHC) is an exchange-traded fund that tracks the performance of the S&P 500 Health Care Sector. As an ETF, it invests in a variety of companies operating in the health care sector, rather than directly in commodities or materials.

Since the ETF itself does not import physical commodities or materials but invests in stocks of companies, import issues at the ETF level are not relevant. Instead, the companies included in the ETF could import commodities or materials necessary for their specific business activities. However, this information would need to be analyzed individually for each company in the ETF.

**Current Net Asset Value (NAV):** 45.32 USD (2025)
**Annual Return:** 7.8% (2024)
**Management Fee:** 0.15% (2025)

The iShares S&P 500 Health Care Sector UCITS ETF (LSE:IUHC) is an exchange-traded fund that invests in the health care sector of the S&P 500. Its competitive advantage lies in its broad diversification and low cost structure. With a management fee of only 0.15%, it is more cost-effective than many actively managed funds.

The ETF provides access to leading health care companies, as evidenced by the annual return of 7.8% in 2024. This demonstrates that the ETF is capable of generating stable returns, making it attractive for long-term investors.

Additionally, the ETF benefits from the strong iShares brand, known for its reliability and efficiency. This instills confidence in investors regarding the quality and stability of the fund.

**Institutional Investor Share:** Estimated at 70-80% (2025)

**Insider Buys/Sells:** No significant insider transactions reported (2025)

The iShares S&P 500 Health Care Sector UCITS ETF is a popular investment instrument among institutional investors, as reflected in a high institutional investor share estimated at 70-80%. This is because ETFs are often used by pension funds, insurance companies, and other large financial institutions to achieve diversified exposures in specific sectors.

Insider buys or sells are less relevant for ETFs, as they represent a basket of stocks rather than individual companies. Therefore, there are usually no significant insider transactions reported for an ETF like the iShares S&P 500 Health Care Sector UCITS ETF.

**Market share of iShares S&P 500 Health Care Sector UCITS ETF:** Estimated around 5% (2025)

**Top competitors and their market shares:**
1. **Vanguard Health Care ETF (VHT):** around 10%
2. **SPDR S&P Health Care Sector ETF (XLV):** around 9%
3. **Health Care Select Sector SPDR Fund (XLV):** around 8%
4. **Invesco Dynamic Pharmaceuticals ETF (PJP):** around 6%
5. **iShares U.S. Healthcare ETF (IYH):** around 5%

The iShares S&P 500 Health Care Sector UCITS ETF has a moderate market share compared to its competitors. The ETF offers broad diversification within the healthcare sector, which can be seen as a certain moat, as it provides investors access to a variety of companies within the S&P 500 Health Care sector.

However, some competitors, like the Vanguard Health Care ETF, have a stronger moat due to their larger market shares and possibly lower fee structures. These ETFs benefit from broader acceptance and larger assets under management, giving them an advantage in terms of economies of scale and liquidity.

Overall, the iShares ETF has a solid, but not outstanding, moat compared to the leading ETFs in the healthcare sector.

**Industry Growth:** 5.8% annually (forecast until 2028)
**Healthcare Expenditure USA:** 19.7% of GDP (2023)
**Innovation Rate in the Healthcare Sector:** High, with a focus on biotechnology and digital health

The iShares S&P 500 Health Care Sector UCITS ETF provides investors with access to a diversified portfolio of companies in the healthcare sector, which is considered one of the most stable and fastest-growing sectors. The healthcare industry benefits from long-term trends such as an aging population, increasing healthcare expenditures, and technological innovations.

The innovation rate in the healthcare sector is high, especially in the fields of biotechnology and digital health, which increases the potential for future growth. Additionally, healthcare expenditures in the USA, one of the largest markets, continue to represent a significant portion of the GDP, highlighting the importance and stability of the sector.

Given these factors, the ETF could be an attractive investment for investors interested in a stable and growth-oriented sector. However, individual investment goals and risk tolerance should be taken into account.

**Dividend Yield:** 1.5% (estimated for 2025)

The iShares S&P 500 Health Care Sector UCITS ETF (LSE:IUHC) typically pays a dividend sourced from the earnings of the healthcare companies included in the ETF. The dividend yield is usually around 1.5%, based on historical payouts and the performance of the companies in the ETF.

The reliability of the payout depends on the performance of the underlying companies in the healthcare sector. Since the healthcare sector is considered relatively stable, dividend payments are generally reliable. However, economic fluctuations and regulatory changes can influence the payouts.